Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McMaster University
$105,000.00
Discovering novel antimicrobials against intracellular pathogens
EF 2018-19
Résumé
There is an urgent need to identify new treatments for multidrug-resistant bacterial infections. The continuous evolution of resistance has rendered many of our frequently prescribed and last-resort antibiotics ineffective, yet very little progress has been made to identify suitable alternatives. Overcoming this global health crisis will require remarkable innovation in antibiotic discovery, to search for drugs that kill bacteria in unique ways. To meet this demand, I propose to screen for small molecules that selectively target and inhibit intracellular bacteria such as Salmonella Typhimurium. Traditional antibiotic discovery efforts have not focused on intracellular pathogens, which reside within host cells during infection and are therefore difficult to eradicate. Our lab has previously established a platform in which to measure antimicrobial activity in the intracellular environment. We now aim to apply this technique to identify new leads for antibiotics that target a highly invasive, multidrug-resistant strain of Salmonella (ST313). ST313 is a distinct, human-adapted lineage of Salmonella, and is capable of causing life-threatening systemic disease. In my proposed research project, I aim to (1) characterize the genetic requirements for intracellular growth of ST313 using RNA-sequencing, (2) identify novel compounds with antibacterial activity against ST313 grown in human macrophages, and (3) determine the mechanism of action of any lead antimicrobial compounds and test for their activity in an animal model of Salmonella infection. This proposed research will help us to unravel the genetic basis of bacterial survival within host cells, while also identifying new treatment alternatives for complicated and recurrent intracellular infections.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
408188
Name
Tsai Caressa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Discovering novel antimicrobials against intracellular pathogens
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Antibiotic Resistance; Bacterial Pathogenesis; Drug Discovery; Host Immunity; Infectious Disease; Intracellular Bacteria; Salmonella Typhimurium
Abstract
There is an urgent need to identify new treatments for multidrug-resistant bacterial infections. The continuous evolution of resistance has rendered many of our frequently prescribed and last-resort antibiotics ineffective, yet very little progress has been made to identify suitable alternatives. Overcoming this global health crisis will require remarkable innovation in antibiotic discovery, to search for drugs that kill bacteria in unique ways. To meet this demand, I propose to screen for small molecules that selectively target and inhibit intracellular bacteria such as Salmonella Typhimurium. Traditional antibiotic discovery efforts have not focused on intracellular pathogens, which reside within host cells during infection and are therefore difficult to eradicate. Our lab has previously established a platform in which to measure antimicrobial activity in the intracellular environment. We now aim to apply this technique to identify new leads for antibiotics that target a highly invasive, multidrug-resistant strain of Salmonella (ST313). ST313 is a distinct, human-adapted lineage of Salmonella, and is capable of causing life-threatening systemic disease. In my proposed research project, I aim to (1) characterize the genetic requirements for intracellular growth of ST313 using RNA-sequencing, (2) identify novel compounds with antibacterial activity against ST313 grown in human macrophages, and (3) determine the mechanism of action of any lead antimicrobial compounds and test for their activity in an animal model of Salmonella infection. This proposed research will help us to unravel the genetic basis of bacterial survival within host cells, while also identifying new treatment alternatives for complicated and recurrent intracellular infections.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tsai, Caressa
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~